Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity

Open Access

Peer-reviewed

Research Article

Robert G. E. Holgate ,

* E-mail: rob.holgate@antitope.com

Affiliation Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom
⨯
Richard Weldon,

Current address: Numab AG, Wädenswil, Switzerland

Affiliation Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom
⨯
Timothy D. Jones,

Affiliation Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom
⨯
Matthew P. Baker

Affiliation Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom
⨯

Reader Comments (0)

Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Hybridomas
Is the Subject Area "Hybridomas" applicable to this article?

Thanks for your feedback.
Cell binding
Is the Subject Area "Cell binding" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.